“…Known Na + /H + antiporters can be classified on the basis of the number of encoding genes into three major groups: (i) single-gene Na + /H + antiporters including NhaA and NhaB ( Herz et al, 2003 ), NhaC ( Ito et al, 1997 ), NhaD ( Zhang et al, 2014 ; Wang et al, 2017 ; Yang et al, 2018 ), NheE ( Sousa et al, 2013 ), NhaG ( Gouda et al, 2001 ), NhaH ( Jiang et al, 2013b ), NhaP ( Utsugi et al, 1998 ), NapA ( Waser et al, 1992 ), and GerN ( Southworth et al, 2001 ); (ii) double-gene Na + /H + antiporters including PsmrAB ( Jiang et al, 2013a ) and UmpAB ( Meng et al, 2017 ); and (iii) multiple-gene Na + /H + antiporters such as Mrp ( Cheng et al, 2016 ; Xu et al, 2018 ), Mnh ( Hiramatsu et al, 1998 ), Pha ( Jiang et al, 2004 ; Yang et al, 2006a ) or Sha ( Kosono et al, 1999 ). In addition, three MFS multi-drug efflux pumps such as MdfA ( Edgar and Bibi, 1997 ), MdtM ( Holdsworth and Law, 2013 ) and Tet(L) ( Cheng et al, 1994 ), and a HCT (2-hydroxy-carboxylate transporter) family transporter MleN ( Wei et al, 2000 ), and a primary Na + pump Nap of NDH (NADH dehydrogenase) family ( Yang et al, 2006b ); and an UPF0118 family protein ( Dong et al, 2017 ), and a RDD family protein ( Shao et al, 2018 ) have also been increasingly reported to be able to function as Na + /H + antiporters. In this study, MdrP was predicted to be a transmembrane protein with 12 putative TMSs (Supplementary Figure S2 ), which was established by the localization of MdrP by western blot in the cytoplasmic membranes of E. coli KNabc ( Figure 2 ).…”